Hereditary colorectal cancer: Molecular analysis of APC and MLH1 genes;Cáncer colorrectal hereditario: Análisis molecular de los genes APC y MLH1

Revista Medica de Chile

Volumn 134, Issue 7, 2006, Pages 841-848

  Bellolio R, Felipe ^a   Álvarez V, Karin ^a,b   De La Fuente L, Marjorie ^b   León G, Francisca ^a   Fullerton M, Demian A ^a   Soto D, Gonzalo ^a   Carvallo De SQ, Pilar ^b   López Köstner, Francisco ^a,c  

^a HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Adenomatous Polyposis Coli; Colorectal neoplasms; Colorectal neoplasms, Hereditary non polyposis; Germ line mutation

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CASE REPORT; COLON POLYPOSIS; COLORECTAL TUMOR; DNA SEQUENCE; FEMALE; GENE FREQUENCY; GENETICS; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; MALE; MIDDLE AGED; MUTATION; PEDIGREE; PHYSIOLOGY; TUMOR SUPPRESSOR GENE;

ADENOMATOUS POLYPOSIS COLI; ADOLESCENT; ADULT; COLORECTAL NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; FEMALE; GENE FREQUENCY; GENES, APC; GERM-LINE MUTATION; HUMANS; MALE; MIDDLE AGED; MUTATION; PEDIGREE; SEQUENCE ANALYSIS, DNA;

EID: 33748490506     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Mortalidad por Causa Específica 2002. Departamento de Estadísticas e Información de Salud. Ministerio de Salud, Chile.
2. WINAWER S, FLETCHER R, REX D, BOND J, BURT R, FERRUCCI J ET AL. Colorectal cancer screening and surveillance: Clinical guidelines and rationale-update based on new evidence. Gastroenterology 2003; 124: 544-60.
3. CHURCH J, SIMMANG C. Practice parameters for the treatment of patients with dominantly inherited colorectal cancer (Familial Adenomatous Polyposis and Hereditary Nonpolyposis Colorectal Cancer). Dis Colon Rectum 2003; 46: 1001-12.
4. RABELO R, FOULKES W, GORDON P, WONG N, YUAN ZQ, MACNAMARA E ET AL. Role of molecular diagnostic testing in familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer families. Dis Colon Rectum 2001; 44: 437-46.
5. LYNCH H, DE LA CHAPELLE A. Hereditary colorectal cancer. N Engl J Med 2003; 348: 919-32.
6. STRATE L, SYNGAL S. Hereditary colorectal cancer syndromes. Cancer Causes Control 2005; 16: 201-13.
7. CAMPBELL W, SPENCE R, PARKS T. Familial adenomatous polyposis. Br J Surg 1994; 81: 1722-3.
8. JANG Y, STEINHAGEN R, HEIMANN T. Colorectal cancer in familial adenomatous polyposis. Dis Colon Rectum 1997; 40: 312-6.
9. KROPILAK M, JAGELMAN D, FAZIO V, LAVERY I, MCGANNON E. Brain tumors in familial adenomatous polyposis. Dis Colon Rectum 1989; 32: 778-82.
10. NORTON I, GOSTOUT C. Management of periampullary adenoma. Dig Dis 1998; 16: 266-73.
11. OFFERHAUS G, ENTIUS M, GIARDIELLO F. Upper gastrointestinal polyps in familial adenomatous polyposis. Hepatogastroenterology 1999; 46: 667-9.
12. SORAVIA C, BERK T, MCLEOD RS, COHEN Z. Desmoid disease in patients with familial adenomatous polyposis. Dis Colon Rectum 2000; 43: 363-9.
13. CHAPMAN P, CHURCH W, BURN J, GUNN A. Congenital hypertrophy of retinal pigment epithelium: a sign of familial adenomatous polyposis. BMJ 1989; 298: 353-4.
14. GRODEN J, THLIVERIS A, SAMOWITZ W, CARLSON M, GELBERT L, ALBERTSEN H ET AL. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991; 66: 589-600.
15. AALTONEN L, SALOVAARA R, KRISTO P, CANZIAN F, HEMMINKI A, PELTOMÄKI P ET AL. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 1998; 338: 1481-7.
16. LYNCH H, SHAW M, MAGNUSON C, LARSEN AL, KRUSH AJ. Hereditary factors in cancer. Study of two large midwestern kindreds. Arch Intern Med 1966; 117: 206-12.
17. FULLERTON DA, LÓPEZ F, RAHMER A. Cáncer colorrectal hereditario no poliposo: tratamiento quirúrgico y análisis de genealogías. Rev Méd Chile 2004; 132: 539-47.
18. SOTO G, LÓPEZ-KÖSTNER F, ZÁRATE A, VULETIN F, RAHMER A, LEÓN F ET AL. Poliposis adenomatosa familiar: alternativas terapéuticas y estudio de los familiares. Rev Méd Chile 2005; 133: 1043-50.
19. LAHIRI DK, NURNBERGER JI. A rapid non-enzimatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 1991; 19: 5444.
20. MIYOSHI Y, ANDO H, NAGASE H, NISHISHO I, HORII A, MIKI Y ET AL. Germ-line mutations of the APC gene in 53 familial adenomatous poliposis patients. Proc Natl Acad Sci 1992; 89: 4452-6.
21. KOLODNER R, HALL N, LIPFORD J, KANE M, MORRISON P, FINAN P ET AL. Structure of the human MLH1 locus and analysis of a large hereditary nonpolyposis colorectal carcinoma kindred for MLH1 mutations. Cancer Res 1995; 55: 242-8.
22. HAN HJ, MARUYAMA M, BABA S, PARK JG, NAKAMURA Y. Genomic structure of human mismatch repair gene, hMLH1, and its mutation analysis in patients with hereditary non-polyposis colorectal cancer. Hum Mol Genet 1995; 4: 237-42.
23. KOLODNER R, HALL N, LIPFORD J, KANE M, RAO MS, MORRISON P ET AL. Structure of the human MSH2 locus and analysis of two Muir-Torre kindreds for MSH2 mutations. Genomics 1994; 24: 516-26.
24. HEISKANEN I, LUOSTARINEN T, JÄRVINEN J. Impact of screening examinations in familial adenomatous polyposis. Scand J Gastroenterol 2000; 35: 1284-7.
25. JÄRVINEN H, AARNIO M, MUSTONEN H, AKTAN-COLLAN K, AALTONEN L, PELTOMÄKI P. Controlled 15-year trial on screening for colorrectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 2000; 118: 829-34.
26. DE VOS TOT NEDERVEEN CAPPEL W, NAGENGAST F, GRIFFIOEN G, MENKO F, TAAL B, KLEIBEUKER J ET AL. Surveillance for hereditary nonpolyposis colorectal cancer. Dis Colon Rectum 2002; 45: 1588-94.
27. WU JS, PUAL P, MCGANNON EA, CHURCH JM. APC genotype, polyp number, and surgical options in familial adenomatous poliposis. Ann Surg 1998; 227: 57-62.
28. CASPARI R, FRIEDL W, MANDL M, MOSLEIN G, KADMON M, KNAPP M ET AL. Familial adenomatous poliposis: mutation at codon 1309 and early onset of cancer. Lancet 1994; 343: 629-32.
29. BERTARIO L, RUSSO A, SALA P, VARESCO L, GIAROLA M, MONDINI P ET AL. Multiple approach to the exploration of genotype-phenotype correlations in familial adenomatous polyposis. J Clin Oncol 2003; 21: 1698-707.
30. FRIEDL W, CASPARI R, SENGTELLER M, UHLHASS S, LAMBERTI C, JUNGCK M ET AL. Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Experience from 680 FAP families. Gut 2001; 48: 515-21.
31. FICARI F, CAMA A, VALANZANO R, CURIA MC, PALMIROTTA R, ACETO G ET AL. APC gene mutations and colorectal adenomatosis in familial adenomatous polyposis. Br J Cancer 2000; 82: 348-53.
32. DISTANTE S, NASIOULAS S, SOMERS GR, CAMERON DJS, YOUNG MA, FORREST SM ET AL. Familial adenomatous polyposis in a 5 year old child: a clinical, pathological, and molecular genetic study. J Med Genet 1996; 33: 157-60.
33. STEINBACH G, LYNCH P, PHILLIPS R, WALLACE M, HAWK E, GORDON G ET AL. The effect of Celecoxib, a cyclooxigenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 2000; 342: 1946-52.
34. ARETZ S, UHLHASS S, CASPARI R, MANGOLD E, PAGENSTECHER C, PROPPING P ET AL. Frequency and parental origin of de novo APC mutations in familial adenomatous poliposis. Eur J Hum Genet 2004; 12: 52-8.
35. LÓPEZ F, ZÚÑIGA A, WISTUBA I. Cáncer colorrectal hereditario no poliposo: bases genéticas del tratamiento quirúrgico. Rev Chil Cir 2002; 54: 107-13.
36. WAGNER A, BARROWS A, WIJNEN J, VAN DER KLIFT H, FRANKEN P, VERKUIJLEN P ET AL. Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: High mutation detection rate among clinically selected families and characterization of an American Founder Genomic Deletion of the MSH2 Gene. Am J Hum Genet 2003; 72: 1088-100.